Abstract
The aim of the present study was to evaluate the effect of astragalosides (ASTs) on angiogenesis, as well as the expression of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) following myocardial infarction (MI). MI was induced in rats by ligation of the left coronary artery. Twenty‑four hours after surgery, the rats were divided into low‑dose, high‑dose, control and sham surgery groups (n=8 per group). The low‑ and high‑dose groups were treated with ASTs (2.5 and 10 mg/kg/day, respectively, via intraperitoneal injection), while, the control and sham surgery group rats received saline. Serum levels, and mRNA and protein expression levels of VEGF and bFGF, as well as the microvessel density (MVD) were determined four weeks post‑treatment. Twenty‑four hours post‑surgery, VEGF and bFGF serum levels were observed to be comparable between the groups; while at four weeks, the VEGF and bFGF levels were higher in the AST‑treated rats (P<0.01). Similarly, VEGF and bFGF mRNA and protein expression levels were higher following AST treatment (P<0.05). No difference in VEGF mRNA expression between the low‑ and high‑dose groups was noted, however, an increase in the bFGF expression levels was detected in t...Continue Reading
References
Oct 1, 1991·Journal of the American College of Cardiology·E R Bates, E J Topol
Mar 1, 1988·Circulation·J M de BakkerR N Hauer
Feb 1, 1997·Nature Medicine·J A Ware, M Simons
Nov 9, 2000·The Journal of Experimental Medicine·F N KaranuM Bhatia
Jan 1, 1997·ILAR Journal·J. Derrell ClarkDennis F. Kohn
Dec 9, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel J Hicklin, Lee M Ellis
Feb 4, 2005·Endocrine Reviews·Ralph T Böttcher, Christof Niehrs
Dec 14, 2005·Circulation·Tuomas T RissanenSeppo Ylä-Herttuala
Sep 27, 2007·Journal of Cellular Physiology·Antonella De LucaNicola Normanno
Dec 19, 2007·Hypertension·Silke MeinersKarl Stangl
Jun 17, 2008·Journal of Vascular Research·Rafif WafaiChristine E Wright
Jan 16, 2009·Heart·S H SchirmerN van Royen
Feb 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Bobby Y ReddyPranela Rameshwar
Jun 16, 2009·Cell·Rui BeneditoRalf H Adams
May 18, 2010·Cardiology in the Young·Anja Pohl-SchickingerBrigitte Stiller
May 27, 2010·The American Journal of Chinese Medicine·Yan-Yan YinGuo-Cui Wu
May 18, 2011·The Journal of Pharmacology and Experimental Therapeutics·Ling ZhangYi Wang
Jul 28, 2011·Drug Design, Development and Therapy·Richard Kones
Nov 3, 2011·Archives of Toxicology·Helén Andersson, Eva Brittebo
Aug 9, 2012·Antioxidants & Redox Signaling·Clement CochainJean-Sébastien Silvestre
Jan 4, 2013·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Mar 9, 2013·Disease Models & Mechanisms·Galina DragnevaSeppo Ylä-Herttuala
Sep 27, 2013·Vascular Cell·Sonia L HernandezDarrell J Yamashiro
Nov 30, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Qing LiuDaping Fan
Mar 7, 2014·Biomolecules & Therapeutics·Masabumi Shibuya
Citations
Jan 19, 2018·Aging and Disease·Ping LiuYumin Luo
Aug 10, 2018·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Xiaoying KongJinsheng Shi
Jul 2, 2020·Pharmaceutical Biology·Lu ChenHong Wang
Mar 25, 2019·Experimental and Therapeutic Medicine·Lei YangBingyu Mao
Dec 9, 2016·PloS One·Shuang HeYan Zhu
Jul 30, 2020·International Journal of Molecular Sciences·Mariantonia BraileStefania Loffredo
Aug 1, 2019·International Journal of Molecular Medicine·Hui JiangWei-Ping Li
Aug 21, 2019·Frontiers in Pharmacology·Ke-Jian ZhangYan Wang
May 15, 2018·Frontiers in Pharmacology·Dongqing GuoXing Chen
Jul 19, 2018·Frontiers in Physiology·Qun ZhengYan Wang
Sep 29, 2020·Drug Design, Development and Therapy·Yu-Qing TanJun Li
Apr 13, 2021·Frontiers in Pharmacology·Yi-Hua ShiWen-Zong Zhu